CRISPR Therapeutics (CRSP) PT Lowered to $90 at Citi

December 3, 2021 5:48 AM EST Send to a Friend

Citi analyst Yigal Nochomovitz lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

CRISPR Therapeutics (CRSP) PT Lowered to $90 at Citi

Member Login

Free News Feed